201 related articles for article (PubMed ID: 20013088)
1. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.
Strege RJ; Kovács G; Meyer JE; Holland D; Claviez A; Mehdorn MH;
Strahlenther Onkol; 2009 Dec; 185(12):789-98. PubMed ID: 20013088
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy as part of the multidisciplinary treatment of childhood rhabdomyosarcomas of the orbit.
Blank LE; Koedooder K; van der Grient HN; Wolffs NA; van de Kar M; Merks JH; Pieters BR; Saeed P; Baldeschi L; Freling NJ; Koning CC
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1463-9. PubMed ID: 19864080
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM
Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298
[TBL] [Abstract][Full Text] [Related]
4. [Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Olivier Pascual N; Calvo JM; Abelairas Gómez JM
Arch Soc Esp Oftalmol; 2005 Jun; 80(6):331-8. PubMed ID: 15986273
[TBL] [Abstract][Full Text] [Related]
5. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
Breneman J; Meza J; Donaldson SS; Raney RB; Wolden S; Michalski J; Laurie F; Rodeberg DA; Meyer W; Walterhouse D; Hawkins DS
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):720-6. PubMed ID: 22104356
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.
Heinzelmann F; Thorwarth D; Lamprecht U; Kaulich TW; Fuchs J; Seitz G; Ebinger M; Handgretinger R; Bamberg M; Weinmann M
Strahlenther Onkol; 2011 Nov; 187(11):715-21. PubMed ID: 22037652
[TBL] [Abstract][Full Text] [Related]
7. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
Casey DL; Wexler LH; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
[TBL] [Abstract][Full Text] [Related]
8. Dose-Effect Analysis of Early Changes in Orbital Bone Morphology After Radiation Therapy for Rhabdomyosarcoma.
Hol MLF; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Lockney NA; Sandler E; Bradley JA
Pract Radiat Oncol; 2020; 10(1):53-58. PubMed ID: 31629089
[TBL] [Abstract][Full Text] [Related]
9. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
Raney RB; Anderson JR; Kollath J; Vassilopoulou-Sellin R; Klein MJ; Heyn R; Glicksman AS; Wharam M; Crist WM; Maurer HM
Med Pediatr Oncol; 2000 Jun; 34(6):413-20. PubMed ID: 10842248
[TBL] [Abstract][Full Text] [Related]
10. The challenging role of radiation therapy for very young children with rhabdomyosarcoma.
Puri DR; Wexler LH; Meyers PA; La Quaglia MP; Healey JH; Wolden SL
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1177-84. PubMed ID: 16682130
[TBL] [Abstract][Full Text] [Related]
11. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Ermoian RP; Breneman J; Walterhouse DO; Chi YY; Meza J; Anderson J; Hawkins DS; Hayes-Jordan AA; Parham DM; Yock TI; Donaldson SS; Wolden SL
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28548706
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
[TBL] [Abstract][Full Text] [Related]
13. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Chen C; Shu HK; Goldwein JW; Womer RB; Maity A
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440
[TBL] [Abstract][Full Text] [Related]
14. ["Spot-scanning" proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI].
Timmermann B; Schuck A; Niggli F; Weiss M; Lomax A; Goitein G
Strahlenther Onkol; 2006 Nov; 182(11):653-9. PubMed ID: 17072523
[TBL] [Abstract][Full Text] [Related]
15. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
[TBL] [Abstract][Full Text] [Related]
16. Clinical research on the treatment effects of radioactive (125)I seeds interstitial brachytherapy on children with primary orbital rhabdomyosarcoma.
Ge X; Ma J; Dai H; Ren L; Li Q; Shi J
Med Oncol; 2014 Sep; 31(9):27. PubMed ID: 25092038
[TBL] [Abstract][Full Text] [Related]
17. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-2004. A nine-month-old boy with an orbital rhabdomyosarcoma.
Friedmann AM; Tarbell NJ; Schaefer PW; Hoch BL
N Engl J Med; 2004 Jan; 350(5):494-502. PubMed ID: 14749459
[No Abstract] [Full Text] [Related]
18. A strategy to avoid facial mutilation in orbital embryonal rhabdomyosarcoma.
Zwerger S; Günther L; Pekrun A; Krause HR; Rustemeyer J
Oral Maxillofac Surg; 2010 Dec; 14(4):233-7. PubMed ID: 20143115
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.
Raney B; Huh W; Hawkins D; Hayes-Jordan A; Million L; Rodeberg D; Teot L; Anderson J;
Pediatr Blood Cancer; 2013 Mar; 60(3):371-6. PubMed ID: 22961750
[TBL] [Abstract][Full Text] [Related]
20. Long term survival in two children with rhabdomyosarcoma of the biliary tract.
Huber J; Sovinz P; Freidl T; Jahnel J; Lackner H; Höllwarth M; Otte JB; Urban C
Klin Padiatr; 2008; 220(6):378-9. PubMed ID: 18949674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
